Octiq Lubricating Eye Drops recalled over sterility concerns
- Recall date
- September 1, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- AMMAN PHARMACEUTICAL INDUSTRIES recalls octiq Lubricating Eye Drops, Dextran 70.01%, Hypromellose 0.3%, 0.5 FL OZ Each (2X 15 mL Bottles), Manufactured for Inn…
- Recall number
- D-1167-2023
- FDA classification
- Class II
- Brand / firm
- AMMAN PHARMACEUTICAL INDUSTRIES
- Sold / distributed
- Product was distributed to two (2) direct accounts in RI and CO.
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
octiq Lubricating Eye Drops, Dextran 70.01%, Hypromellose 0.3%, 0.5 FL OZ Each (2X 15 mL Bottles), Manufactured for Innovus Pharmaceuticals, Inc., Englewood, CO 80112, Made in Jordan, NDC:57483-610-15.
Get recall alerts
Free email alert whenever AMMAN PHARMACEUTICAL INDUSTRIES has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AMMAN PHARMACEUTICAL INDUSTRIES